WSJ
27 Oct 2026, 07:40 UTC · 1h ago
Reckitt Cuts Outlook After Lysol Issues Stunt North America Sales
Impact · against what's priced in
The North American revenue decline confirms the market's skepticism regarding regional growth, providing no positive catalyst. While the company anticipates a Q4 rebound, the market is not currently paying for a North American volume recovery, making the outlook shift a neutral-to-negative confirmation of existing weakness.
- CL−0.10
Already priced in
- The price assumes
International growth in Latin America and Asia Pacific, which the market accepts as real but offset by North American weakness.
The 1.3% fall in North American net revenue validates the market's current assumption that regional weakness is offsetting growth elsewhere. Because the price already discounts a North American recovery, the anticipated Q4 rebound is not yet a catalyst.
What CL's price assumes · Sep 22
Top 2 movers · tap to explore
